IRIS
DE LUCA, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.283
EU - Europa 1.988
NA - Nord America 1.709
SA - Sud America 308
AF - Africa 57
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.651
SG - Singapore 1.217
RU - Federazione Russa 1.012
CN - Cina 500
IT - Italia 411
BR - Brasile 255
HK - Hong Kong 239
DE - Germania 155
VN - Vietnam 151
NL - Olanda 73
FI - Finlandia 70
GB - Regno Unito 64
IN - India 64
FR - Francia 32
ES - Italia 30
KR - Corea 26
MX - Messico 25
UA - Ucraina 25
AR - Argentina 24
IE - Irlanda 24
CA - Canada 22
PL - Polonia 21
BD - Bangladesh 18
CI - Costa d'Avorio 17
ZA - Sudafrica 17
GR - Grecia 15
JP - Giappone 13
SE - Svezia 12
EC - Ecuador 11
AT - Austria 8
LT - Lituania 8
TR - Turchia 8
IQ - Iraq 7
ID - Indonesia 5
PY - Paraguay 5
UZ - Uzbekistan 5
AL - Albania 4
BE - Belgio 4
CZ - Repubblica Ceca 4
EG - Egitto 4
JO - Giordania 4
KE - Kenya 4
PK - Pakistan 4
AU - Australia 3
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
SA - Arabia Saudita 3
VE - Venezuela 3
AD - Andorra 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
JM - Giamaica 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
RO - Romania 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TV - Tuvalu 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
YT - Mayotte 1
Totale 6.354
Salva come PNG Salva come JPEG
Città #
Singapore 583
Chandler 256
Moscow 239
Hong Kong 237
Beijing 166
Ashburn 141
Hefei 119
Naples 82
Munich 69
Santa Clara 68
Los Angeles 67
Millbury 61
Napoli 57
Ho Chi Minh City 55
Amsterdam 43
Des Moines 40
Lawrence 35
Redondo Beach 34
Boston 30
Helsinki 30
Hanoi 26
São Paulo 26
New York 25
Seoul 25
Kochi 21
Buffalo 20
Dallas 20
Falkenstein 20
Wilmington 20
Princeton 19
Rome 19
Orem 18
Warsaw 18
Valencia 17
Frankfurt am Main 16
Nanjing 16
Atlanta 15
Turku 15
Heraklion 14
Milan 14
London 13
Seattle 13
Tokyo 13
Rio de Janeiro 12
Fairfield 11
Johannesburg 11
Nanchang 11
Brooklyn 10
Chennai 10
Chicago 10
Denver 10
Dublin 9
Mexico City 9
Montreal 9
Nuremberg 9
Stockholm 9
The Dalles 9
Dong Ket 8
Haiphong 8
Belo Horizonte 7
Houston 7
Hải Dương 7
Lappeenranta 7
San Francisco 7
Ankara 6
Da Nang 6
Guangzhou 6
Hebei 6
Poplar 6
Salerno 6
Biên Hòa 5
Campinas 5
Düsseldorf 5
Ottawa 5
Phoenix 5
Salvador 5
Santa Maria 5
Tashkent 5
Woodbridge 5
Amman 4
Baghdad 4
Berlin 4
Bologna 4
Brasília 4
Buenos Aires 4
Jiaxing 4
Mumbai 4
Münster 4
Nairobi 4
Norwalk 4
Olomouc 4
Pomigliano d'Arco 4
Portsmouth 4
San Jose 4
Sciacca 4
Shenyang 4
Vienna 4
Bexley 3
Brusciano 3
Brussels 3
Totale 3.187
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 179
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 156
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 130
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 126
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 125
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 125
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 118
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 118
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 115
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 114
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 113
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 110
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 110
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 108
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 108
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 108
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 107
Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer 103
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 103
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 101
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 100
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 100
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 99
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 98
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 98
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 98
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 97
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 96
Methods for actionable gene fusion detection in lung cancer: now and in the future 96
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 95
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 94
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 94
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 94
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 94
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 93
Predictive molecular pathology in the time of COVID-19 93
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 91
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 91
PD-L1 and beyond: Immuno-oncology in cytopathology 91
EGFR mutation detection by microfluidic technology: a validation study. 90
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 90
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 89
EGFR analysis: Current evidence and future directions 87
Tumor mutational burden on cytological samples: A pilot study 87
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 87
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 86
Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer 86
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 85
Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm 85
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 84
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 81
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 80
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 80
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 77
Critical aspects of MSI testing in endometrial cancer: a comparison study 75
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice? 75
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 75
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 74
Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): Towards an in-house molecular prognostication for pathologists? 73
SIMULTANEOUS VULVAR AND PARENCHIMAL BRAIN LANGERHANS CELL HISTIOCYTOSIS: ASSOCIATION OR COINCIDENCE? 70
Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective 67
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 66
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 64
Epidermal Growth Factor Receptor Test Performed on Liquid-Based Cytology Lung Samples: Experience of an Academic Referral Center. 63
Nanoscale Prognosis of Colorectal Cancer Metastasis from AFM Image Processing of Histological Sections 54
The development of a narrow target gene panel makes next generation sequencing effective for circulating free DNA analysis 54
Clear Cell Neoplasm in Salivary Gland FNA? Maybe It’s From Kidney! 50
The relevance of the reference range for EGFR testing in non-small cell lung cancer patients 45
Molecular predictive testing in precision oncology: The Italian experience 45
Evaluation of a New Ethanol-Based Preservative Medium for Liquid-Based Cervical Cytology: A Performance Pilot Study for Molecular Applications 38
Understanding EGFR heterogeneity in lung cancer 33
Totale 6.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021147 0 0 0 0 0 31 10 36 17 26 9 18
2021/2022359 9 4 5 9 5 3 4 32 30 38 91 129
2022/2023575 58 37 25 51 71 69 0 70 106 41 31 16
2023/2024332 26 69 31 17 12 9 16 56 11 3 55 27
2024/20252.282 84 139 11 11 67 97 212 140 124 304 897 196
2025/20262.491 444 331 454 369 738 155 0 0 0 0 0 0
Totale 6.484